Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.

K. Brosen*, E. Skjelbo, H. Flachs

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review


1. A sparteine/mephenytoin phenotyping test was carried out in 37 Vietnamese living in Denmark. By visual inspection the urinary S/R‐ mephenytoin ratio appeared to show a bimodal frequency distribution. Eight putative poor metabolizers of mephenytoin, PMm (22%), had S/R‐ mephenytoin ratios from 0.79 to 1.12 and 29 putative extensive metabolizers of mephenytoin, EMm, had S/R‐mephenytoin ratios < or = 0.55. All of the subjects were extensive metabolizers of sparteine with urinary metabolic ratios from 0.15 to 2.4. 2. The metabolism of the antimalarial prodrug proguanil was studied in 34 of the subjects after a single oral dose of 100 mg. The median 12 h urinary recoveries of the active metabolite cycloguanil and the minor metabolite 4‐ chlorphenylbiguanide were 5.8 and 1.9% of the dose, respectively, in 26 EMm compared with 1.6 and 0.4%, respectively, in 8 PMm (P < 0.001, Mann‐ Whitney U‐test). 3. There was no statistically significant correlation (Spearmans rs) between any index of proguanil metabolism and the sparteine metabolic ratio. 1993 The British Pharmacological Society

Original languageEnglish
JournalBritish Journal of Clinical Pharmacology
Issue number2
Pages (from-to)105-108
Number of pages4
Publication statusPublished - 1. Jan 1993


Cite this